ID   ATS1_HUMAN              Reviewed;         967 AA.
AC   Q9UHI8; D3DSD5; Q9NSJ8; Q9P2K0; Q9UH83; Q9UP80;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-JUL-2015, entry version 155.
DE   RecName: Full=A disintegrin and metalloproteinase with thrombospondin motifs 1;
DE            Short=ADAM-TS 1;
DE            Short=ADAM-TS1;
DE            Short=ADAMTS-1;
DE            EC=3.4.24.-;
DE   AltName: Full=METH-1;
DE   Flags: Precursor;
GN   Name=ADAMTS1; Synonyms=KIAA1346, METH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-227.
RA   Casas C., Pritchard M.A., Estivill X., Arbones M.L.;
RT   "Cloning, characterization and mapping on human chromosome 21 of the
RT   orthologue of murine Adamts-1.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT PRO-227, AND FUNCTION.
RC   TISSUE=Heart;
RX   PubMed=10438512; DOI=10.1074/jbc.274.33.23349;
RA   Vazquez F., Hastings G., Ortega M.-A., Lane T.F., Oikemus S.,
RA   Lombardo M., Iruela-Arispe M.L.;
RT   "METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new
RT   family of proteins with angio-inhibitory activity.";
RL   J. Biol. Chem. 274:23349-23357(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-227.
RC   TISSUE=Endothelial cell;
RX   PubMed=10785405; DOI=10.1046/j.1432-1327.2000.01325.x;
RA   Glienke J., Schmitt A.O., Pilarsky C., Hinzmann B., Weiss B.,
RA   Rosenthal A., Thierauch K.H.;
RT   "Differential gene expression by endothelial cells in distinct
RT   angiogenic states.";
RL   Eur. J. Biochem. 267:2820-2830(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T.,
RA   Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y.,
RA   Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K.,
RA   Polley A., Menzel U., Delabar J., Kumpf K., Lehmann R., Patterson D.,
RA   Reichwald K., Rump A., Schillhabel M., Schudy A., Zimmermann W.,
RA   Rosenthal A., Kudoh J., Shibuya K., Kawasaki K., Asakawa S.,
RA   Shintani A., Sasaki T., Nagamine K., Mitsuyama S., Antonarakis S.E.,
RA   Minoshima S., Shimizu N., Nordsiek G., Hornischer K., Brandt P.,
RA   Scharfe M., Schoen O., Desario A., Reichelt J., Kauer G., Bloecker H.,
RA   Ramser J., Beck A., Klages S., Hennig S., Riesselmann L., Dagand E.,
RA   Wehrmeyer S., Borzym K., Gardiner K., Nizetic D., Francis F.,
RA   Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 418-967.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 253-548 ALONE AND IN COMPLEX
RP   WITH INHIBITOR, ACTIVE SITE, COFACTOR, ZINC-BINDING SITES,
RP   CALCIUM-BINDING SITES, AND DISULFIDE BONDS.
RX   PubMed=17897672; DOI=10.1016/j.jmb.2007.07.047;
RA   Gerhardt S., Hassall G., Hawtin P., McCall E., Flavell L.,
RA   Minshull C., Hargreaves D., Ting A., Pauptit R.A., Parker A.E.,
RA   Abbott W.M.;
RT   "Crystal structures of human ADAMTS-1 reveal a conserved catalytic
RT   domain and a disintegrin-like domain with a fold homologous to
RT   cysteine-rich domains.";
RL   J. Mol. Biol. 373:891-902(2007).
CC   -!- FUNCTION: Cleaves aggrecan, a cartilage proteoglycan, and may be
CC       involved in its turnover (By similarity). Has angiogenic inhibitor
CC       activity. Active metalloprotease, which may be associated with
CC       various inflammatory processes as well as development of cancer
CC       cachexia. May play a critical role in follicular rupture.
CC       {ECO:0000250, ECO:0000269|PubMed:10438512}.
CC   -!- CATALYTIC ACTIVITY: Cleaves aggrecan at the 1938-Glu-|-Leu-1939
CC       site, within the chondroitin sulfate attachment domain.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:17897672};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:17897672};
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix {ECO:0000250}.
CC   -!- DOMAIN: The spacer domain and the TSP type-1 domains are important
CC       for a tight interaction with the extracellular matrix.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch
CC       motif binds the catalytic zinc ion, thus inhibiting the enzyme.
CC       The dissociation of the cysteine from the zinc ion upon the
CC       activation-peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase.
CC       {ECO:0000250}.
CC   -!- PTM: Glycosylated. Can be O-fucosylated by POFUT2 on a serine or a
CC       threonine residue found within the consensus sequence C1-X(2)-
CC       (S/T)-C2-G of the TSP type-1 repeat domains where C1 and C2 are
CC       the first and second cysteine residue of the repeat, respectively.
CC       Fucosylated repeats can then be further glycosylated by the
CC       addition of a beta-1,3-glucose residue by the glucosyltransferase,
CC       B3GALTL. Fucosylation mediates the efficient secretion of ADAMTS
CC       family members. Also can be C-glycosylated with one or two mannose
CC       molecules on tryptophan residues within the consensus sequence W-
CC       X-X-W of the TPRs, and N-glycosylated. These other glycosylations
CC       can also facilitate secretion (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Contains 1 disintegrin domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 peptidase M12B domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00276}.
CC   -!- SIMILARITY: Contains 3 TSP type-1 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00210}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD48080.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA92584.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ADAMTS1ID574ch21q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF170084; AAF15317.1; -; mRNA.
DR   EMBL; AF060152; AAD48080.1; ALT_INIT; mRNA.
DR   EMBL; AF207664; AAF23772.1; -; mRNA.
DR   EMBL; AB037767; BAA92584.1; ALT_INIT; mRNA.
DR   EMBL; AP001697; BAA95502.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09951.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09952.1; -; Genomic_DNA.
DR   EMBL; AL162080; CAB82413.1; -; mRNA.
DR   CCDS; CCDS33524.1; -.
DR   PIR; T47158; T47158.
DR   RefSeq; NP_008919.3; NM_006988.4.
DR   UniGene; Hs.643357; -.
DR   PDB; 2JIH; X-ray; 2.10 A; A/B=253-548.
DR   PDB; 2V4B; X-ray; 2.00 A; A/B=253-548.
DR   PDB; 3Q2G; X-ray; 2.30 A; A/B=256-548.
DR   PDB; 3Q2H; X-ray; 2.33 A; A/B=256-548.
DR   PDBsum; 2JIH; -.
DR   PDBsum; 2V4B; -.
DR   PDBsum; 3Q2G; -.
DR   PDBsum; 3Q2H; -.
DR   ProteinModelPortal; Q9UHI8; -.
DR   SMR; Q9UHI8; 256-844, 851-905, 910-962.
DR   BioGrid; 114888; 12.
DR   IntAct; Q9UHI8; 2.
DR   STRING; 9606.ENSP00000284984; -.
DR   BindingDB; Q9UHI8; -.
DR   ChEMBL; CHEMBL5133; -.
DR   MEROPS; M12.222; -.
DR   PhosphoSite; Q9UHI8; -.
DR   BioMuta; ADAMTS1; -.
DR   DMDM; 124053460; -.
DR   MaxQB; Q9UHI8; -.
DR   PaxDb; Q9UHI8; -.
DR   PeptideAtlas; Q9UHI8; -.
DR   PRIDE; Q9UHI8; -.
DR   DNASU; 9510; -.
DR   Ensembl; ENST00000284984; ENSP00000284984; ENSG00000154734.
DR   GeneID; 9510; -.
DR   KEGG; hsa:9510; -.
DR   UCSC; uc002ymf.3; human.
DR   CTD; 9510; -.
DR   GeneCards; GC21M028208; -.
DR   HGNC; HGNC:217; ADAMTS1.
DR   HPA; CAB016394; -.
DR   HPA; HPA031498; -.
DR   HPA; HPA031499; -.
DR   MIM; 605174; gene.
DR   neXtProt; NX_Q9UHI8; -.
DR   PharmGKB; PA24536; -.
DR   eggNOG; NOG291688; -.
DR   GeneTree; ENSGT00760000118880; -.
DR   HOGENOM; HOG000004799; -.
DR   HOVERGEN; HBG004313; -.
DR   InParanoid; Q9UHI8; -.
DR   KO; K08617; -.
DR   OMA; CPDNNGK; -.
DR   OrthoDB; EOG7WDN1M; -.
DR   PhylomeDB; Q9UHI8; -.
DR   TreeFam; TF331949; -.
DR   BRENDA; 3.4.24.B11; 2681.
DR   BRENDA; 3.4.24.B12; 2681.
DR   Reactome; REACT_118572; Degradation of the extracellular matrix.
DR   Reactome; REACT_264269; O-glycosylation of TSR domain-containing proteins.
DR   ChiTaRS; ADAMTS1; human.
DR   EvolutionaryTrace; Q9UHI8; -.
DR   GeneWiki; ADAMTS1; -.
DR   GenomeRNAi; 9510; -.
DR   NextBio; 35638; -.
DR   PMAP-CutDB; Q9UHI8; -.
DR   PRO; PR:Q9UHI8; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   Bgee; Q9UHI8; -.
DR   CleanEx; HS_ADAMTS1; -.
DR   ExpressionAtlas; Q9UHI8; baseline and differential.
DR   Genevisible; Q9UHI8; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:Ensembl.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IEA:InterPro.
DR   GO; GO:0008237; F:metallopeptidase activity; TAS:ProtInc.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071374; P:cellular response to parathyroid hormone stimulus; IEA:Ensembl.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEA:Ensembl.
DR   GO; GO:0060347; P:heart trabecula formation; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0044691; P:tooth eruption; IEA:Ensembl.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR006586; ADAM_Cys-rich.
DR   InterPro; IPR010294; ADAM_spacer1.
DR   InterPro; IPR024079; MetalloPept_cat_dom.
DR   InterPro; IPR013274; Pept_M12B_ADAM-TS1.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR013273; Peptidase_M12B_ADAM-TS.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   InterPro; IPR000884; Thrombospondin_1_rpt.
DR   Pfam; PF05986; ADAM_spacer1; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   Pfam; PF01421; Reprolysin; 1.
DR   Pfam; PF00090; TSP_1; 3.
DR   PRINTS; PR01858; ADAMTS1.
DR   PRINTS; PR01857; ADAMTSFAMILY.
DR   SMART; SM00608; ACR; 1.
DR   SMART; SM00209; TSP1; 3.
DR   SUPFAM; SSF82895; SSF82895; 3.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50092; TSP1; 3.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cleavage on pair of basic residues;
KW   Complete proteome; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Heparin-binding; Hydrolase; Metal-binding; Metalloprotease;
KW   Polymorphism; Protease; Reference proteome; Repeat; Secreted; Signal;
KW   Zinc; Zymogen.
FT   SIGNAL        1     49       {ECO:0000255}.
FT   PROPEP       50    252       {ECO:0000250}.
FT                                /FTId=PRO_0000029150.
FT   CHAIN       253    967       A disintegrin and metalloproteinase with
FT                                thrombospondin motifs 1.
FT                                /FTId=PRO_0000029151.
FT   DOMAIN      258    467       Peptidase M12B. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00276}.
FT   DOMAIN      476    559       Disintegrin.
FT   DOMAIN      559    614       TSP type-1 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      854    905       TSP type-1 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      908    967       TSP type-1 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   REGION      725    849       Spacer.
FT   MOTIF       196    203       Cysteine switch. {ECO:0000250}.
FT   COMPBIAS    617    724       Cys-rich.
FT   COMPBIAS    843    846       Poly-Lys.
FT   ACT_SITE    402    402       {ECO:0000255|PROSITE-ProRule:PRU00276,
FT                                ECO:0000255|PROSITE-ProRule:PRU10095,
FT                                ECO:0000269|PubMed:17897672}.
FT   METAL       198    198       Zinc; in inhibited form. {ECO:0000250}.
FT   METAL       261    261       Calcium 1.
FT   METAL       261    261       Calcium 2.
FT   METAL       344    344       Calcium 1.
FT   METAL       344    344       Calcium 2; via carbonyl oxygen.
FT   METAL       351    351       Calcium 1.
FT   METAL       401    401       Zinc; catalytic.
FT   METAL       405    405       Zinc; catalytic.
FT   METAL       411    411       Zinc; catalytic.
FT   METAL       462    462       Calcium 1; via carbonyl oxygen.
FT   METAL       465    465       Calcium 1.
FT   METAL       465    465       Calcium 2.
FT   CARBOHYD    547    547       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    720    720       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    764    764       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    333    385       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    362    367       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    379    462       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    417    446       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    488    511       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    499    521       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    506    540       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    534    545       {ECO:0000269|PubMed:17897672}.
FT   DISULFID    571    608       {ECO:0000250}.
FT   DISULFID    575    613       {ECO:0000250}.
FT   DISULFID    586    598       {ECO:0000250}.
FT   VARIANT     227    227       A -> P (in dbSNP:rs428785).
FT                                {ECO:0000269|PubMed:10438512,
FT                                ECO:0000269|PubMed:10785405,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_030001.
FT   CONFLICT    468    468       Q -> H (in Ref. 1; AAF15317).
FT                                {ECO:0000305}.
FT   CONFLICT    561    561       S -> N (in Ref. 1; AAF15317).
FT                                {ECO:0000305}.
FT   STRAND      258    266       {ECO:0000244|PDB:2V4B}.
FT   HELIX       268    274       {ECO:0000244|PDB:2V4B}.
FT   HELIX       275    277       {ECO:0000244|PDB:2V4B}.
FT   HELIX       278    293       {ECO:0000244|PDB:2V4B}.
FT   HELIX       296    298       {ECO:0000244|PDB:2V4B}.
FT   STRAND      302    311       {ECO:0000244|PDB:2V4B}.
FT   HELIX       315    317       {ECO:0000244|PDB:2V4B}.
FT   HELIX       325    336       {ECO:0000244|PDB:2V4B}.
FT   HELIX       337    339       {ECO:0000244|PDB:2V4B}.
FT   STRAND      351    359       {ECO:0000244|PDB:2V4B}.
FT   STRAND      371    373       {ECO:0000244|PDB:2V4B}.
FT   TURN        381    383       {ECO:0000244|PDB:2V4B}.
FT   STRAND      385    389       {ECO:0000244|PDB:2V4B}.
FT   HELIX       395    406       {ECO:0000244|PDB:2V4B}.
FT   HELIX       415    417       {ECO:0000244|PDB:2V4B}.
FT   TURN        418    420       {ECO:0000244|PDB:2V4B}.
FT   HELIX       445    456       {ECO:0000244|PDB:2V4B}.
FT   TURN        457    460       {ECO:0000244|PDB:2V4B}.
FT   HELIX       461    464       {ECO:0000244|PDB:2V4B}.
FT   HELIX       478    481       {ECO:0000244|PDB:2V4B}.
FT   HELIX       484    492       {ECO:0000244|PDB:2V4B}.
FT   STRAND      510    513       {ECO:0000244|PDB:2JIH}.
FT   STRAND      520    523       {ECO:0000244|PDB:2JIH}.
FT   STRAND      538    541       {ECO:0000244|PDB:2V4B}.
FT   STRAND      544    548       {ECO:0000244|PDB:2V4B}.
SQ   SEQUENCE   967 AA;  105358 MW;  334119D6310A05A7 CRC64;
     MQRAVPEGFG RRKLGSDMGN AERAPGSRSF GPVPTLLLLA AALLAVSDAL GRPSEEDEEL
     VVPELERAPG HGTTRLRLHA FDQQLDLELR PDSSFLAPGF TLQNVGRKSG SETPLPETDL
     AHCFYSGTVN GDPSSAAALS LCEGVRGAFY LLGEAYFIQP LPAASERLAT AAPGEKPPAP
     LQFHLLRRNR QGDVGGTCGV VDDEPRPTGK AETEDEDEGT EGEDEGAQWS PQDPALQGVG
     QPTGTGSIRK KRFVSSHRYV ETMLVADQSM AEFHGSGLKH YLLTLFSVAA RLYKHPSIRN
     SVSLVVVKIL VIHDEQKGPE VTSNAALTLR NFCNWQKQHN PPSDRDAEHY DTAILFTRQD
     LCGSQTCDTL GMADVGTVCD PSRSCSVIED DGLQAAFTTA HELGHVFNMP HDDAKQCASL
     NGVNQDSHMM ASMLSNLDHS QPWSPCSAYM ITSFLDNGHG ECLMDKPQNP IQLPGDLPGT
     SYDANRQCQF TFGEDSKHCP DAASTCSTLW CTGTSGGVLV CQTKHFPWAD GTSCGEGKWC
     INGKCVNKTD RKHFDTPFHG SWGMWGPWGD CSRTCGGGVQ YTMRECDNPV PKNGGKYCEG
     KRVRYRSCNL EDCPDNNGKT FREEQCEAHN EFSKASFGSG PAVEWIPKYA GVSPKDRCKL
     ICQAKGIGYF FVLQPKVVDG TPCSPDSTSV CVQGQCVKAG CDRIIDSKKK FDKCGVCGGN
     GSTCKKISGS VTSAKPGYHD IITIPTGATN IEVKQRNQRG SRNNGSFLAI KAADGTYILN
     GDYTLSTLEQ DIMYKGVVLR YSGSSAALER IRSFSPLKEP LTIQVLTVGN ALRPKIKYTY
     FVKKKKESFN AIPTFSAWVI EEWGECSKSC ELGWQRRLVE CRDINGQPAS ECAKEVKPAS
     TRPCADHPCP QWQLGEWSSC SKTCGKGYKK RSLKCLSHDG GVLSHESCDP LKKPKHFIDF
     CTMAECS
//
